Fennec Pharmaceuticals (TSE:FRX) Share Price Crosses Below Fifty Day Moving Average – Time to Sell?

Fennec Pharmaceuticals Inc. (TSE:FRX) shares crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$9.40 and traded as low as C$9.21. Fennec Pharmaceuticals shares last traded at C$9.21, with a volume of 201 shares trading hands.

Fennec Pharmaceuticals Stock Performance

The firm has a market cap of C$163.53 million, a price-to-earnings ratio of -143.65 and a beta of 0.25. The firm’s 50 day moving average price is C$9.41 and its 200-day moving average price is C$8.11. The company has a debt-to-equity ratio of -620.83, a current ratio of 7.80 and a quick ratio of 10.17.

Insider Activity

In related news, Director Rostislav Christov Raykov sold 7,569 shares of Fennec Pharmaceuticals stock in a transaction dated Wednesday, March 5th. The stock was sold at an average price of C$9.71, for a total value of C$73,503.54. In the last 90 days, insiders sold 21,186 shares of company stock worth $196,017. 16.20% of the stock is currently owned by corporate insiders.

Fennec Pharmaceuticals Company Profile

Fennec Pharmaceuticals Inc operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons.